This was the stock's second consecutive day of losses.

IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 2.86% on an annualized basis producing an average annual return of 11.3%. Currently, IDEXX Laboratories has a market ...

For the most recent quarter, Idexx was expected to post earnings of $2.96 per share, but it reported $2.92 per share instead, representing a surprise of 1.37%.

WESTBROOK, Maine, June 24, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for ...

What if you'd invested in Idexx Laboratories (IDXX) ten years ago? It may not have been easy to hold on to IDXX for all that time, but if you did, how much would your investment be worth today ...

In other recent news, IDEXX Laboratories reported its first-quarter 2025 earnings, which surpassed analyst expectations with an earnings per share (EPS) of $2.96, beating the forecast of $2.86.

IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst ...

Investing.com - Jefferies initiated coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Buy rating and a $625.00 price target on Tuesday. The stock, currently trading at $536.34, sits near its 52 ...

2025 Investor Day IDEXX Laboratories, Inc. will host its 2025 Investor Day on Thursday, August 14, 2025, at its corporate headquarters in Westbrook, Maine from 8:00 am to approximately 12:00 pm EDT.

Shares of IDEXX Laboratories Inc. IDXX slid 1.55% to $520.59 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.84% to ...